AHM 2011 Alyn Morice University of Hull HYMS COPD Disease not Disorder?

Slides:



Advertisements
Similar presentations
COPD Or Chronic Bronchitis That Was Dr Bruce Davies.
Advertisements

New COPD GOLD Classification
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Bronchoprovocation test Presented by: Ashraf Abbas ELMaraghy,MD. Lecturer of Chest Diseases, Ain Shams University.
Is it really COPD? Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal Hospital Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal.
BACKGROUND & AIM THE IMPACT OF GERD ON EXACERBATIONS OF COPD HAS NEVER BEEN EVALUATED. TO DETERMINE THE PREVALENSI OF GER SYMPTOMS IN COPD PATIENTS.
Academy Board Prep PCCM
Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
Physiology Lab Spirometry
Professor of Respiratory Medicine
Epidemiology and Public Health Introduction, Part II.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.
COPD (Chronic Obstructive Pulmonary Disease)
Chronic Obstructive Pulmonary Disease Natasha Chowdhury.
Lung Volumes Inspiratory Reserve Volume:
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
BY….. Evelyn Kihunde, Linda A. Dufie, Richie Isom 1.
Respiratory COPD/Asthma.
The National Lung Health Education Program Programs for the Respiratory Therapist.
PULMONARY FUNCTION TESTS
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Mental Status Changes. History 52 y o female presented to the ED with mental status changes Bradycardia noted in ED.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
An Approach For Spirometry and DLCO Interpretation
Presenting Organization Event Name Event Date Presenter Name, Title COPD Essentials for Physicians
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Respiratory System Disorders. Infectious Diseases  Caused by viruses or bacteria  Bronchitis  Pneumonia  Tuberculosis (TB)  Common Cold.
COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.
Disorders of the Respiratory System PAGES
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Disorders of the Respiratory System By : Amir Ashkan Ashrafian M.D.
Dr. Taj. What is Spirometry ? It is a measurement of the breathing capacity of the lungs. It is the most basic and frequently performed test of pulmonary.
Emphysema Bianca Dinh. Outline Vocabulary Overview Diagnosis Treatment Risk Factors Conclusion Works Cited.
Maggie Harris Independent Respiratory Nurse Specialist
Long Term Effects Of Tobacco Use TSWBBAT Describe how tobacco use affects the body systems -short term and long term.
Diabetes: 0–44 years Ranked comorbidity combinations Source: ABS Australian Health Survey 2011–12 (National Health Survey component) For people aged 0–44,
Pulmonary function test. Evaluation of pulmonary function is important in many clinical situations evaluation of a variety of forms of lung disease assessing.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
J R Hurst Thorax : Depart. Of Pulmonology R3 백승숙.
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Obstructive Lung Disease and Low Lung Function in.
COPD 2003.
An effective COPD case finding strategy in Primary Care
PFT of the Day!.
GARD Meeting Beijing Formulate and Adopt Policy WG 3: Diagnosis of CRD and Allergy
Respiratory Disorders
Blood eosinophils as a biomarker in alpha 1 antitrypsin deficiency
Schema depicting chronic obstructive pulmonary disease (COPD)
The Respiratory System
Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.
Respiratory Disorders and Diseases
Legend Suppl Fig.1- Risk of COPD according to plasma levels of C-reactive protein (CRP) among never smokers (A) and ever smokers (B). Multiple adjustment.
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
David B. Price, MBBChir, MA, FRCGP, Barbara P
Chronic obstructive pulmonary disease (COPD)
Flow diagram of participants included in the survey. aResponse rate
M. Inghammar, G. Engström, G. Kahlmeter, B. Ljungberg, C. -G
An Interprofessional Approach to the Patient With Chronic Airway Disease.
Respiratory System Disorders
Volume 97, Issue 1, Pages (January 1990)
High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects  William Busse, MD, Sheldon Spector, MD, Karin Rosén,
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.
E. Rand Sutherland, MD, MPH  Journal of Allergy and Clinical Immunology 
The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study  Tetyana.
WELCOME TO THE CME ON “CURRENT CONCEPTS IN THE MANAGEMENT OF COPD”
Scatter plot of body mass index (BMI) versus forced expiratory volume in the first second (FEV1), and linear correlation lines for normal spirometry and.
Forest plot from meta-analysis carried out on four studies including high-dose N-acetylcysteine (NAC) treatment a) assessing the relative risk of chronic.
Airway inflammation in chronic obstructive pulmonary disease
Presentation transcript:

AHM 2011 Alyn Morice University of Hull HYMS COPD Disease not Disorder?

What is COPD? Asthma (eosinophilic bronchitis) Emphysema Chronic Bronchitis (neutrophilic bronchitis)

2010

Page 1 of 673!

COPD Treatment Pathway Establish diagnosis of COPD in at risk population with history, examination and spirometry (FEV 1 /FEV ratio <70%) Establish severity of disease by FEV 1 as % predicted Management of RISK FACTORS plus EDUCATION plus IMMUNISATION Pulmonary rehabilitation if functionally disabled – (Ensure treatment is optimised) SMOKING CESSATION Lifestyle Advice Diet/Exercise Influenza vax (annual) Pneumococcal vax. Psychological Issues PHARMACOLOGICAL TREATMENT Review at each step after one month before escalating treatment THEOPHYLLINETHEOPHYLLINE MUCOLYTICSMUCOLYTICS prn short acting β 2 agonist Tiotropium + short acting β 2 agonist SHORTNESS OF BREATH Consider Palliative Care Referral in End Stage Disease Tiotropium + long acting β 2 agonist (LABA)* *salmeterol, eformoterol or indercaterol Tiotropium + combination LABA and inhaled corticosteroid (Seretide 500 accuhaler or Symbicort 200/6) COUGH AND SPUTUM Roflumilast + Tiotropium + short acting β 2 agonist (  Weight loss) Tiotropium + combination LABA and inhaled corticosteroid (Seretide 500 accuhaler or Symbicort 200/6)

Telemonitoring in COPD – the evidence base Numerous pilot projects with accompanying evaluation reports; – Often exceptionally good results (e.g. COPD telehealth in SE Essex – 75% reduction in A&E attendances; 83% reduction in hospital admissions) – Often methodologically limited (e.g. before-and-after studies; small sample sizes) Systematic reviews demonstrate that high-quality evidence base is still immature; – Bolton (2010): studies included were positive but of a low- quality – Polisena (2010): Telehealth interventions improved QoL and reduced hospitalisations

Best health, best health care, a health service fit for the East Riding Evaluation… Evaluation of first 3 months deployment (24 patients) showed: -Patient satisfaction generally very good -68% reduction in n/e admission costs -net saving per month -achievement of £0.5m QIPP saving feasible Evaluation by Hull University – full year evaluation due Dec 11

Best health, best health care, a health service fit for the East Riding The East Riding Model Risk stratification identifies patient MDT agrees intervention Protocols for response in place: GP, NCT, specialist services, secondary care GP’s/NCT 1. Referral for telehealth intervention 2. Patient registered & unit installed Patient at risk of deterioration 2. Alerts 3. Triage 4. Response 1. Monitoring IDENTIFY REFER MONITOR RESPOND Telephone patient Visit - within identified timescale Emergency Response Step up / Step down Community Beds

Telemonitoring in COPD – How can it work?

Telemonitoring in COPD – suggested mechanisms of action It has been suggested that telemonitoring can support COPD patients by; – Providing reassurance and support

Telemonitoring in COPD – suggested mechanisms of action It has been suggested that telemonitoring can support COPD patients by; – Increasing knowledge of disease process and enhancing self-care – Providing reassurance and support

Best health, best health care, a health service fit for the East Riding Roger 64 year old with chronic, severe COPD Housebound and anxious Frequently uses standby medication Frequent hospital admissions – anxiety rather than healthcare need Distrustful of clinicians due to previous experience After telehealth: Telephone contact to reassure Patient keeps diary of results and more knowledgeable about condition eg, trends/patterns More proactive about asking for help Reduced hospital admissions

Telehealth then... 14

Telemonitoring in COPD – suggested mechanisms of action It has been suggested that telemonitoring can support COPD patients by; – Enabling earlier detection of exacerbation (e.g. due to reporting of worsening symptoms) – Increasing knowledge of disease process and enhancing self- care – Providing reassurance and support

The impact of frequent COPD exacerbations - more frequent attacks increase mortality Soler-Cataluna JJ, et al. Thorax 2005;60:925–931 Group A: no exacerbations Group B: 1–2 exacerbations Group C: ≥3 exacerbations n=304 Time (months) p< p< A B C p= Survival probability

COPD patients with productive cough More likely to have exacerbations More likely to have exacerbations Seemungal TA et al. Am J Respir Crit Care Med 98 More rapid decline in lung function More rapid decline in lung function Vestbo J 1996, Kanner RA et al. Am J Respir Crit Care Med 01 More likely to die early More likely to die early Prescott E et al. Eur Respir J 1995

% of patients On Later in the In the In the At night Waking morning afternoon evening Breathlessness (n=1,769) Chest tightness (n=690) Timing of symptoms: when was each symptom the most troublesome? 19 % of patients On Later in the In the In the At night Waking morning afternoon evening % of patients On Later in the In the In the At night Waking morning afternoon evening Cough (n=1,433) % of patients On Later in the In the In the At night Waking morning afternoon evening Phlegm (n=1,551) Partridge et al. ERS Vienna 2009

HULL AIRWAYS REFLUX QUESTIONNAIRE Name: D.O.B:____________________________ UN: _________________ DATE OF TEST: Please circle the most appropriate response for each question Within the last MONTH, how did the following problems affect you? 0 = no problem and 5 = severe/frequent problem Hoarseness or a problem with your voice Clearing your throat Excess mucus in the throat, or drip down the back of your nose Retching or vomiting when you cough Cough on first lying down or bending over Chest tightness or wheeze when coughing Heartburn, indigestion, stomach acid coming up (or do you take medications for this, if yes score 5) A tickle in your throat, or a lump in your throat Cough with eating (during or straight after meals) Cough with certain foods Cough when you get out of bed in the morning Cough brought on by singing or speaking (for example, on the telephone) Coughing during the day rather than night A strange taste in your mouth TOTAL SCORE_____________ /70

History of Cough Recording Woolf & Rosenberg,Thorax 1964:19;125

History of Cough Recording Woolf & Rosenberg,Thorax 1964:19;125

unprocessed file processed file Waveforms showing acoustic events – Pre and post filtering

Cough counting in exacerbations of COPD Day coughs Day coughs

Future of telemonitoring in COPD 25